Alessia Capone
Rome, 00179, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis.
Journal: Cancers
Published: February 10, 2026
Colonic Polyp Regression After Nous-209 Cancer Immunotherapy: A Clinical Trial Case Report.
Journal: Journal of immunotherapy and precision oncology
Published: November 18, 2025
Phase I Trial of Viral Vector-Based Personalized Vaccination Elicits Robust Neoantigen-Specific Antitumor T-Cell Responses.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 15, 2023
Insight into immune profile associated with vitiligo onset and anti-tumoral response in melanoma patients receiving anti-PD-1 immunotherapy.
Journal: Frontiers in immunology
Published: March 31, 2023
Inhibition of the PI3K/AKT/mTOR signaling promotes an M1 macrophage switch by repressing the ATF3-CXCL8 axis in Ewing sarcoma.
Journal: Cancer letters
Published: October 06, 2022
Assessment of T-cell Reactivity to the SARS-CoV-2 Omicron Variant by Immunized Individuals.
Journal: JAMA network open
Published: April 22, 2022
Th17 and Th1 cells in systemic lupus erythematosus with focus on lupus nephritis.
Journal: Immunologic research
Published: April 01, 2022
Caspase-8 as a novel mediator linking Src kinase signaling to enhanced glioblastoma malignancy.
Journal: Cell death and differentiation
Published: February 07, 2022
Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients.
Journal: Scientific reports
Published: August 13, 2021
Identification and Purification of Human Memory T Helper Cells from Peripheral Blood.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 30, 2021
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma.
Journal: Molecular oncology
Published: June 09, 2020
Last Updated: 09/26/2026